RIC alloBMT w PTCy in refractory SSc ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
51全身性強皮症1

51. 全身性強皮症


臨床試験数 : 525 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05298358
(ClinicalTrials.gov)
November 18, 20227/3/2022RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic SclerosisA Phase I Study of Reduced Intensity Conditioning Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide for Refractory Systemic SclerosisSystemic SclerosisBiological: RIC alloBMT w PTCy in refractory SScSidney Kimmel Comprehensive Cancer Center at Johns HopkinsNULLRecruiting18 Years65 YearsAll30Phase 1United States